Taiwan Healthcare Expo: Bridging International Markets and Digital Innovations

The Era of Digital Healthcare: Among Europe's strongholds, one Asian country is confidently leading the way in this field—Taiwan. According to KOTRA's overseas market trends, Taiwan's digital healthcare market is projected to grow rapidly, from approximately 8.7 billion Taiwan dollars in 2020 to 14.2 billion Taiwan dollars by next year.

Taiwan is one of the most open and supportive environments for digital healthcare among Asian countries. The government, medical institutions, and companies collaborate to advance the industry, exemplified by the launch of the Digital Healthcare Alliance in 2020, which fosters cross-sector partnerships. In October this year, Taiwan's Ministry of Health and Welfare (MOHW) took a concrete step toward advancing digital healthcare technology by establishing a specialized AI center in collaboration with 16 hospitals.

Taiwan also fosters international exchange among healthcare companies, with the annual Taiwan Healthcare Expo serving as a prime example. This event combines major corporations with cutting-edge medical technologies to establish strategic partnerships. This year's expo, which began on December 5, is scheduled to run until December 8.

The expo also provides an excellent opportunity for Korean companies to explore international markets. AHEALTHZ participated in the event alongside its strategic partners, drawing significant attention from overseas companies.

AHEALTHZ is a healthcare technology supply platform that distributes various medical devices and pharmaceuticals. Earlier this year, the company established an in vitro diagnostics research center and built GMP-certified manufacturing facilities, securing the capability to produce medical devices in-house.

Leveraging these advancements, AHEALTHZ has been actively expanding its reach through direct investments and joint ventures with overseas medical institutions, particularly in East Asia. It has also forged multiple strategic partnerships with other companies to foster business collaboration, demonstrating its proactive approach to growth and innovation.

MECOVI, TR, MEDIHUB, and AIOBIO were among the partner companies that participated in the expo alongside AHEALTHZ. Together with AHEALTHZ, these four companies showcased their excellent products and explored opportunities for entering overseas markets.

TR has developed the AI-powered respiratory function testing system Spirokit, which addresses the limitations of traditional diagnostic devices and facilitates early diagnosis in clinical settings. Following its partnership with AHEALTHZ, TR signed an exclusive distribution agreement with a local company in Vietnam. This resulted in the system's deployment in Vietnamese health centers and significant success in international markets. At this expo, TR continued to showcase Spirokit, further driving efforts to expand its global exports.

MEDIHUB has developed i-JECT, a digital painless automatic injector incorporating a pain-reduction algorithm created by faculty at Seoul National University Dental Hospital through clinical research. This innovation helps medical professionals minimize human error during injections, preventing medical accidents and ensuring patients receive safe and pain-free treatment. At the expo, MEDIHUB introduced this new concept in injection procedures, which aims to enhance satisfaction for healthcare providers and patients, garnering significant attention from international companies.

AIOBIO, an AI-driven digital healthcare company, has developed the Biofluorescence Imaging System (BIS) and the oral health management platform LINKDENS, ushering in a new paradigm for diagnosing and managing oral diseases. In July last year, AIOBIO entered into an investment agreement with AHEALTHZ and has since been actively exploring the oral disease diagnostic market through AHEALTHZ's extensive overseas sales network. AIOBIO provided an in-depth introduction to BIS and LINKDENS at this year's expo, setting a new benchmark for oral care in the digital healthcare era.

Junyeon Kim, CEO of AHEALTHZ, stated, "AHEALTHZ is focused on supporting the global expansion of outstanding domestic companies and fostering sustainable growth with our international partner firms. Participating in this expo is particularly meaningful as it offers an opportunity to introduce exceptional products to the global market and create tangible opportunities for domestic companies to enter and establish themselves in overseas markets through AHEALTHZ."

During the expo, AHEALTHZ strengthened its strategic partnerships with Taiwanese companies by signing a memorandum of understanding (MOU) with H2U, a digital healthcare platform specialist, and TopMed International Biotech, a pharmaceutical and medical device distribution company.

This agreement was initiated to strengthen Taiwan's local business cooperation network and secure opportunities for discovering new ventures. AHEALTHZ plans to establish a collaborative framework with the two companies for medical devices and related technologies while enhancing local marketing and distribution efforts to accelerate its expansion into the Taiwanese healthcare market.

H2U is a digital healthcare platform specialist company spun off from Taiwan's Foxconn Group. It offers AI-driven personalized health management services. It operates a platform used by approximately 70% of Taiwan's health check-up institutions, positioning itself as a leader in the digital healthcare sector. In November last year, H2U entered into a strategic investment and business collaboration partnership with AHEALTHZ to establish a digital healthcare platform.

Topmed International Biotech specializes in the distribution of pharmaceuticals and medical devices and provides biotechnology research and development services. The company is expected to play a pivotal role in supporting AHEALTHZ's distribution operations for its entry into the Taiwanese market.